With support from SNF as part of its Global Health Initiative, Memorial Sloan Kettering Cancer Center (MSK) is bringing its deep expertise in pediatric oncology to patients around the globe through the establishment of the SNF Global Pediatric Cancer Program. The program aims to expand access to excellent care through new collaborations and peer exchanges with hospitals and health care providers worldwide.
As part of this new program, MSK will create new relationships and build on existing ones with current SNF GHI partners, including Sant Joan de Déu (SJD) Barcelona Children’s Hospital, where SNF supported the construction of the new SJD Pediatric Cancer Center; King Hussein Cancer Foundation and Center in Jordan, where SNF is helping expand access for children from the wider region; and Yorkshire Cancer Research in the UK where SNF supports scaling an exercise-based treatment program to improve outcomes. The SNF Global Pediatric Cancer Program will also support the development and future provision of pediatric cancer care at the SNF University Pediatric Hospital of Thessaloniki, one of three state-of-the-art hospitals currently under construction in Greece as part of the GHI. As the SNF Global Pediatric Cancer Program advances beyond the initial implementation phase, the network of institutions it encompasses will expand with individually tailored partnerships.
The SNF Global Pediatric Cancer Program aims to optimize outcomes for young patients globally by facilitating access to primary diagnosis, treatment guidance, and state-of-the-art molecular testing. It will also incorporate peer consultations for clinicians, who will have input from a Global Disease Management Team including pediatric oncologists, radiologists, pathologists, and surgeons. The program will also offer a range of specialized training and educational opportunities, as well as an SNF Fellowship in Global Health for a junior investigator.
MSK and the participating institutions will explore potential opportunities for translational research and clinical trials.
Based in New York, MSK is a renowned Comprehensive Cancer Center with expertise in precision cancer medicine, neuro-oncology, transplant and cellular therapies, and palliative care, among much else. MSK Kids is the largest pediatric oncology program in the United States.
